doi:10.3892/mmr.2017.6321 10
In-Person (Insurance): $882 more expensive but saves 36+ hours For Tirzepatide (18 Months): Telehealth (TrimRx): $349 18 = $6,282 In-Person (Weight Loss Clinic): $800 18 = $14,400 Savings: $8,118 Insurance Considerations With Insurance: Pros of In-Person: May have better insurance acceptance Copays might be reasonable Prior authorization process familiar Cons of In-Person: Prior authorization hassles May be denied High copays still expensive Deductible considerations Telehealth with Insurance: Some telehealth covered now Often still need prior auth Copays similar to in-person Convenience advantage remains Without Insurance (Cash Pay): Clear Winner: Telehealth Dramatically lower cost Transparent pricing No authorization needed Faster access HSA/FSA Considerations: Both Options HSA/FSA Eligible: Consultations covered Medications covered Pre-tax savings (20-30%) Makes telehealth even more affordable: $199/month = ~$140-160 after tax benefit $349/month = ~$245-280 after tax benefit Bottom Line on Cost: For Most People: Telehealth is significantly less expensive Especially compounded options Saves time and transportation costs Equivalent medical care Better convenience Telehealth Makes Sense When: Paying cash or high copays Want maximum convenience Live far from specialists Have busy schedule Comfortable with technology In-Person Makes Sense When: Excellent insurance with low copays Complex medical situation Strong preference for face-to-face Need hands-on support TrimRx telehealth pricing offers the best value for cash-pay patients seeking GLP-1 treatment
Watch her full presentation here #WorldPsoriasisDay #StopTheDominoEffect #WPD2025 #Comorbidities To view or add a comment, sign in As a doctor, Ive often seen patients walk into the clinic feeling perfectly fine only to discover dangerously high blood pressure levels
This time, MEDVi showed up and filed an answer, admitting it markets and sells semaglutides to consumers but denies sending unlawful texts or knowing who John Doe is
(30,31) The authors acknowledged several limitations, including the use of a national patient database, which restricted their ability to control for prior diabetes management and preoperative glycemic control
Also keep in mind that out-of-pocket costs can vary depending on insurance coverage
